Verghese C, De Leon J, Simpson G M
Medical College of Pennsylvania/EPPI, Philadelphia 19129.
Neuropsychopharmacology. 1993 Sep;9(2):157-66. doi: 10.1038/npp.1993.54.
Polydipsia and water intoxication cause considerable morbidity and mortality in chronic psychiatric patients. The pathophysiology of the disorder is unknown, and there is no effective treatment. Angiotensin II is an important dipsogen in animals; in humans, some conditions with abnormal thirst are associated with increased angiotensin function. Chronic D2 dopamine receptor blockade increases angiotensin II-induced thirst in animals; in humans, increased peripheral response to angiotensin II is documented. Chronic D2 blockade with typical neuroleptics may increase sensitivity to angiotensin II and induce thirst. Clozapine, which has negligible D2 blocking action may improve polydipsia. Recent case reports demonstrate improvement of polydipsia during clozapine therapy. Angiotensin II releases vasopressin; this could explain water intoxication, which occurs later in the syndrome. This paper suggests an etiological model and a treatment modality for this disorder.
烦渴与水中毒在慢性精神病患者中会导致相当高的发病率和死亡率。该病症的病理生理学尚不清楚,且没有有效的治疗方法。血管紧张素II是动物体内一种重要的致渴剂;在人类中,一些伴有异常口渴的病症与血管紧张素功能增强有关。慢性D2多巴胺受体阻断会增加动物体内血管紧张素II诱导的口渴感;在人类中,也有外周对血管紧张素II反应增强的记录。使用典型抗精神病药物进行慢性D2阻断可能会增加对血管紧张素II的敏感性并诱发口渴。氯氮平具有可忽略不计的D2阻断作用,可能会改善烦渴症状。近期的病例报告表明在氯氮平治疗期间烦渴症状有所改善。血管紧张素II会释放抗利尿激素;这可以解释在该综合征后期出现的水中毒现象。本文提出了针对该病症的病因模型和治疗方式。